Case Studies & WhitepapersMay 22, 2026
Process Development and Quality Research Strategy for Dual-Payload Conjugated Drugs
What is the mainstream conjugation process for antibodies and siRNA?
Biologics and ConjugatesMar 11, 2026
Optimization of Synthetic Process and Metal-Chelation Impurity Control Strategy for Complex Peptide-based RDCs
It fully demonstrates the strength of Porton's one-stop RDC service platform, excellent project management capabilities, and efficient production and operation.
Small MoleculesFeb 28, 2026
The Perfect Integration of Immobilized Enzymes and Flow Chemistry: A Powerful Booster for the Commercialization of Biocatalysis Technology
Adhering to Porton's core value of “Pursuing Excellence”, the Porton biocatalysis team has designated "enzyme immobilization technology and its industrialization" as a core strategic technology.
Small MoleculesJan 31, 2026
Process Simulation Platform: Enabling Process Development and Scale-up of Active Pharmaceutical Ingredients
The Porton Crystallization team has the capability to perform process simulation of unit operations, including solvent swap, crystallization, filtration and drying.
Small MoleculesJan 15, 2026
A Decisive Milestone for On-time, On-budget Project Delivery
This case study demonstrates how rigorous analytical logic, disciplined execution, and targeted experimentation can resolve complex chromatographic challenges.
Small MoleculesDec 08, 2025
Optimizing Process Chemistry for Enhanced Pharmaceutical Manufacturing
Process Chemistry Optimization | Pharma Manufacturing
Small MoleculesOct 30, 2025
Expert Q&A: How to Efficiently Apply Preparative Chromatography in Drug Research
How to Efficiently Apply Preparative Chromatography in Drug Research
Small MoleculesSep 24, 2025
Biocatalysis: A Powerful and Possible Greener Tool for Chemists in the Pharmaceutical Industry
End-to-end Enzyme Solutions
Small MoleculesSep 23, 2025
Expert Q&A: Molecular Simulation and Data Science Support of Porton
Explore virtual screening duration, differences from property optimization, and crystal structure requirements for impurity rejection calculations.
